Skip to main content

Kendall Capital Management

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1731372 ROCKVILLE, MD

Position in REGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,369,293
-$265,613 QoQ
Shares Held
2,196
+3.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#589
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Kendall Capital Management holds $6,297,958 across 5 Biotechnology names. REGN ranks #3 (21.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
2,196 $1,369,293

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,369,293 2,196
2026-03-31 $1,634,906 2,116
2025-12-31 $1,640,223 2,125
2025-09-30 $1,194,261 2,124
2025-06-30 $1,117,200 2,128
2025-03-31 $1,402,916 2,212
2024-12-31 $1,657,591 2,327
2024-09-30 $2,467,260 2,347
2024-06-30 $2,540,339 2,417
2024-03-31 $2,393,712 2,487
2023-12-31 $2,368,748 2,697
2023-09-30 $2,281,245 2,772
2023-06-30 $2,173,583 3,025
2023-03-31 $2,530,743 3,080
2022-12-31 $1,809,496 2,508
2022-09-30 $1,734,574 2,518
2022-06-30 $1,493,785 2,527
2022-03-31 $1,601,477 2,293
2021-12-31 $1,441,760 2,283
2021-09-30 $1,425,198 2,355
2021-06-30 $1,339,378 2,398
2021-03-31 $1,134,589 2,398
2020-12-31 $1,099,558 2,276
2020-09-30 $1,212,483 2,166
2020-06-30 $1,397,599 2,241
2020-03-31 $1,128,438 2,311